Jane Street Group LLC trimmed its stake in shares of Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR – Free Report) by 31.4% during the third quarter, HoldingsChannel reports. The fund owned 14,553 shares of the company’s stock after selling 6,656 shares during the quarter. Jane Street Group LLC’s holdings in Amplify Weight Loss Drug & Treatment ETF were worth $390,000 as of its most recent SEC filing.
Separately, Harbour Investments Inc. raised its stake in shares of Amplify Weight Loss Drug & Treatment ETF by 43.4% in the 3rd quarter. Harbour Investments Inc. now owns 9,563 shares of the company’s stock valued at $256,000 after purchasing an additional 2,895 shares in the last quarter.
Amplify Weight Loss Drug & Treatment ETF Stock Performance
Shares of NYSEARCA THNR opened at $22.67 on Wednesday. The stock’s 50 day moving average price is $23.82 and its two-hundred day moving average price is $25.68. Amplify Weight Loss Drug & Treatment ETF has a 52-week low of $22.00 and a 52-week high of $28.19.
Recommended Stories
- Five stocks we like better than Amplify Weight Loss Drug & Treatment ETF
- Investing In Preferred Stock vs. Common Stock
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- How to Buy Cheap Stocks Step by Step
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Want to see what other hedge funds are holding THNR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR – Free Report).
Receive News & Ratings for Amplify Weight Loss Drug & Treatment ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amplify Weight Loss Drug & Treatment ETF and related companies with MarketBeat.com's FREE daily email newsletter.
